References

Endogenous angiogenesis inhibitors

10.1111/j.1600-0463.2004.apm11207-0809.x · 2004 · External reference

Angiogenesis and its control in the female reproductive system

10.1258/0007142001903364 · 2000 · External reference

Tumorigenesis and the angiogenic switch

10.1038/nrc1093 · 2003 · External reference

Regulation of angiogenesis by the hemostatic system

10.2741/998 · 2003 · External reference

Fibrinolysis and angiogenesis in wound healing

10.1002/path.1711650406 · 1991 · External reference

Tumors: wounds that do not heal

1986 · External reference

Tumor angiogenesis: therapeutic implications

10.1056/nejm197111182852108 · 1971 · External reference

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

10.1200/jco.2005.10.017 · 2005 · External reference

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

10.1200/jco.2005.02.2574 · 2006 · External reference

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth

10.1111/j.1582-4934.2002.tb00307.x · 2002 · External reference

Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice

10.1007/s00280-003-0712-y · 2004 · External reference

The structure of human thrombospondins, an adhesive glycoprotein with multiple calcium binding sites and homologies with several different proteins

10.1083/jcb.103.5.1635 · 1986 · External reference

Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat

10.1016/s0026-895x(24)12032-9 · 1999 · External reference

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics

10.1002/ijc.10247 · 2002 · External reference

10.1200/jco.2008.26.15_suppl.3524

10.1200/jco.2008.26.15_suppl.3524 · External reference

Assay and purification of naturally occurring inhibitor of angiogenesis

10.1016/0076-6879(91)98044-7 · 1991 · External reference

Evolution of potent and stable placental-growth-factor-1-targeting CovX-bodies from phage display peptide discovery

10.1021/jm101226k · 2011 · External reference

Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth

10.1158/1078-0432.ccr-10-2317 · 2011 · External reference

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

10.1016/s0002-9440(10)65140-1 · 1999 · External reference

Selective activity against proliferating tumor endothelial cells by CVX-22, a thrombospondin-1 mimetic CovX-Body

2009 · External reference

an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer

10.1093/annonc/mdq260 · 2010 · External reference

Safety and efficacy of combining sunitinib with bevacizumab + paclitaxel/carboplatin in non-small cell lung cancer

10.1097/jto.0b013e3181c7307e · 2010 · External reference